Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer

NCT00287885 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Endometrial Cancer
Fallopian Tube Cancer
Ovarian Cancer
Peritoneal Cavity Cancer
Sarcoma
Vaginal Cancer
Vulvar Cancer

Interventions

DRUG: docetaxel

Sponsor

Masonic Cancer Center, University of Minnesota